Tempest Therapeutics licenses intellectual property to cancer target from University of California Sep. 14, 2021
Discovery of apigenin derivative with potential to overcome drug-resistant MET-mutant RCC Sep. 14, 2021
USAMRIID to test Navrogen's small-molecule NK cell activators against SARS-CoV-2 infection Sep. 14, 2021
Twist Bioscience and Adicet collaborate on discovery of gamma delta T-cell cancer therapies Sep. 14, 2021
RSS